Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03718338 · ClinicalTrials.gov registry record
Mechanisms of Metabolic and Hormone Action on Plaque Formation in Brain and Carotid Vessels in Patients With Prostate Adenocarcinoma
A clinical trial, sponsored by University of Washington.
- Terminated
- Registry status
- 2
- Enrollment target
NCT03718338 is a clinical trial that was terminated before completion, run by University of Washington. The registered enrollment target is 2 participants.
The verdict
NCT03718338 was terminated before completion, sponsored by University of Washington.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
This trial studies the mechanisms of metabolic and hormone action on plaque formation in brain and carotid vessels in patients with prostate adenocarcinoma. Studying the biomarkers in the laboratory may help doctors know the impact of androgen deprivation on metabolic, brain and cardiovascular endpoints.
Interventions
- OTHER Quality-of-Life Assessment
- PROCEDURE Evaluation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2019-10-08 |
| Est. Completion | 2020-03-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03718338
The ClinicalTrials.gov registry entry for NCT03718338 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Quality-of-Life Assessment is the first listed.
NCT03718338 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03718338 about?
NCT03718338 is a clinical study titled "Mechanisms of Metabolic and Hormone Action on Plaque Formation in Brain and Carotid Vessels in Patients With Prostate Adenocarcinoma". This trial studies the mechanisms of metabolic and hormone action on plaque formation in brain and carotid vessels in patients with prostate adenocarcinoma. Studying the biomarkers in the laboratory may help doctors know the impact of androgen deprivation on metabolic, brain and cardiovascular endpo...
What is the current status of trial NCT03718338?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2019-10-08. Estimated completion is 2020-03-12.
What interventions are being tested in trial NCT03718338?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Evaluation (PROCEDURE).
Who is sponsoring clinical trial NCT03718338?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.